OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AEON

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

AEON Biopharma (AEON) Ownership - Who owns AEON Biopharma?

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

5 Park Plaza

Phone

+1 949 354-6499

Employees

Web

https://www.aeonbiopharma.com

Details

Group

Domestic Stock Funds

Fundamentals

AEON

Capitalization

8.25M

P/E Ratio

0.00

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

16.2M

Total Cash/Share

1.43

Total Debt

16.5M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

-32.09M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

0.22

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

5.31M

Shares Outstanding - Current

11.3M

Total Liabilities

36.1M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-98.408

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology